With M&A Deal, Click Therapeutics' Digital Prospects in Metabolic Disease Get Better - MedCity NewsClick Therapeutics acquired Better Therapeutics to broaden its reach in cardiometabolic disorders, leveraging Better's FDA-authorized type 2 diabetes mobile app for personalized treatment plans.